- Conditions
- Peritonitis, Peritonitis Bacterial
- Interventions
- Dalbavancin
- Drug
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- Aurora, California
Source: ClinicalTrials.gov public record
Updated May 8, 2024 · Synced May 21, 2026, 7:25 PM EDT